Medication-Assisted Treatment: What It Is, How It Works, and Why It Saves Lives

The Most Misunderstood Treatment in Recovery

Medication-assisted treatment (MAT) is simultaneously one of the most evidence-based and most stigmatized approaches in addiction medicine. Studies consistently show that MAT reduces overdose deaths, decreases illicit drug use, improves treatment retention, and helps people rebuild their lives. Yet it remains underutilized, misunderstood, and sometimes actively discouraged — even within recovery communities.

This article explains what MAT is, how the major medications work, what the evidence says, and why the common objection — "you're just trading one addiction for another" — reflects a misunderstanding of both addiction and treatment.

What Is Medication-Assisted Treatment?

MAT is the use of FDA-approved medications, in combination with counseling and behavioral therapies, to treat substance use disorders. The "assisted" in medication-assisted treatment is important: medications are not a standalone cure. They work best as part of a comprehensive treatment approach that includes therapy, peer support, and attention to the social and environmental factors that drive substance use.

MAT is currently most developed for opioid use disorder and alcohol use disorder, though research is ongoing for stimulant and cannabis use disorders.

Medications for Opioid Use Disorder

Buprenorphine (Suboxone, Subutex, Sublocade) is a partial opioid agonist — it activates opioid receptors, but less strongly than full agonists like heroin or oxycodone. This partial activation is enough to prevent withdrawal and reduce cravings without producing the intense euphoria of full agonists. Suboxone combines buprenorphine with naloxone (an opioid antagonist) to deter injection misuse. Buprenorphine can be prescribed by certified physicians, nurse practitioners, and physician assistants in office-based settings — meaning patients can receive it at a regular doctor's office rather than a specialized clinic. Research shows buprenorphine reduces overdose mortality by 50% or more.

Methadone is a full opioid agonist that activates opioid receptors completely, eliminating withdrawal and cravings. Because of its abuse potential, methadone for opioid use disorder must be dispensed through federally regulated opioid treatment programs (OTPs), typically requiring daily clinic visits initially. Methadone has the longest track record of any MAT medication — decades of research show it reduces illicit opioid use, overdose deaths, criminal activity, and HIV transmission. For people with severe opioid use disorder who have not responded to other treatments, methadone is often the most effective option.

Naltrexone (Vivitrol) is an opioid antagonist — it blocks opioid receptors completely, preventing opioids from producing any effect. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance. It is available as a daily pill or a monthly injection (Vivitrol). The challenge with naltrexone is that it requires complete opioid detoxification before starting — any opioids in the system will cause immediate withdrawal. This makes it harder to initiate than buprenorphine. But for motivated patients who have completed detox, naltrexone is highly effective and eliminates concerns about diversion or misuse.

Medications for Alcohol Use Disorder

Naltrexone also works for alcohol use disorder. It reduces the rewarding effects of alcohol and decreases cravings. Research shows it reduces heavy drinking days and increases abstinence rates. It is available as a daily pill or monthly injection. The COMBINE study, one of the largest alcohol treatment trials ever conducted, found naltrexone to be effective both with and without behavioral therapy.

Acamprosate (Campral) works differently from naltrexone — it reduces the glutamate hyperactivity that occurs during alcohol withdrawal and early abstinence, decreasing the dysphoria and anxiety that drive relapse. It is most effective for people who are already abstinent and want to maintain abstinence. It requires three doses per day and is not effective for people who are still drinking.

Disulfiram (Antabuse) works by blocking the metabolism of alcohol, causing an unpleasant reaction (flushing, nausea, palpitations) when alcohol is consumed. It is a deterrent rather than a craving-reducer. Its effectiveness depends heavily on adherence — it only works if the person takes it. Supervised administration (by a family member or clinic) significantly improves outcomes.

Addressing "Trading One Addiction for Another"

The most common objection to MAT — particularly to buprenorphine and methadone — is that it simply replaces one addiction with another. This objection reflects a misunderstanding of what addiction is.

Addiction is not defined by physical dependence. Physical dependence — the body adapting to a substance so that stopping causes withdrawal — can occur with many medications that are not addictive, including blood pressure medications and antidepressants. Addiction is defined by compulsive use despite negative consequences, loss of control, and the substance dominating a person's life.

A person taking buprenorphine as prescribed is not experiencing compulsive use, loss of control, or a substance dominating their life. They are taking a medication that stabilizes their brain chemistry, prevents withdrawal, and allows them to function normally. This is analogous to a person with diabetes taking insulin — the insulin creates physical dependence, but no one calls it "trading one addiction for another."

The evidence is unambiguous: people on MAT have dramatically better outcomes than people who attempt abstinence without medication. They are less likely to die, less likely to use illicit drugs, more likely to maintain employment and relationships, and more likely to stay in treatment. Withholding effective medication from people with a life-threatening condition because of ideological objections to medication is not principled — it is harmful.

MAT and 12-Step Programs

The relationship between MAT and 12-step programs has historically been complicated. Some AA and NA groups have discouraged or excluded people on MAT, viewing it as incompatible with sobriety. This position has softened in recent years — AA's official literature does not prohibit medication use, and many groups now welcome people on MAT. But attitudes vary widely by group and region.

If you are on MAT and want to participate in 12-step programs, you may need to find groups that are welcoming of medication use. Many such groups exist. You are not obligated to disclose your medication status, and your recovery is valid regardless of whether you are on medication.

Access and Barriers

Despite its effectiveness, MAT remains inaccessible to many people who need it. Barriers include: shortage of waivered prescribers, particularly in rural areas; cost and insurance coverage gaps; stigma from healthcare providers; requirements for frequent clinic visits; and lack of awareness among patients and families.

Efforts to expand access include: the removal of the X-waiver requirement for buprenorphine prescribing (now any DEA-licensed provider can prescribe it), expansion of telehealth for MAT, and increased insurance coverage requirements. But significant gaps remain.

If you are seeking MAT, SAMHSA's treatment locator (findtreatment.gov) can help you find providers in your area. The SAMHSA National Helpline (1-800-662-4357) can also connect you with local resources.

MAT Is Not Forever — Unless It Needs to Be

Some people use MAT for a defined period — to stabilize, build recovery skills, and then taper off under medical supervision. Others use it indefinitely, as a long-term management strategy for a chronic condition. Both approaches are valid. The decision about duration should be made collaboratively between the patient and their provider, based on individual circumstances — not based on arbitrary timelines or ideological preferences.

The goal of MAT is not to be on medication forever. The goal is recovery — a life free from the domination of addiction, with restored relationships, functioning, and wellbeing. For many people, medication is an essential tool in achieving that goal.